麻豆传媒

Meeting Coverage >

ESC

ESC Leaders See Hybrid Meetings as the Future

The society is also actively looking eastward for future meetings

Polypill Proves Its Mettle for Heart Protection Post-MI

Trial affirms benefit of single drug-combo pill compared with usual care in secondary prevention

No Detrimental Impact on Cognition With Entresto for Heart Failure

Cost may be reason for underutilization, rather than concerns about cognition, expert noted

DAPT for 1 Month Falls Short in Acute Coronary Syndrome

STOPDAPT-2 ACS results can't match positive findings from earlier trials

ADT Options for Prostate Cancer Come Out Even for Heart Safety

But low enrollment brought PRONOUNCE trial to an early close

Continuous Monitoring With Implantable Loop Recorder Finds More Afib

But preventing strokes? That's a different story.

LAA Occluder Opens Doors to Patients Who Can't Tolerate Blood Thinners Even Briefly

The Amulet IDE trial that led to Amplatzer Amulet's FDA approval

Can Image-Guided Fibrosis Ablation Help in Persistent Afib?

Targeting fibrosis in afib with minimal fibrotic disease may improve outcomes, says researcher

Stenting or Surgery for Patients With Carotid Artery Stenosis?

No differences in outcomes seen between groups

Good Results When Giving Flu Shots to MI Survivors Still in the Hospital

Vaccination prior to discharge linked to heart benefit

Faster Not Better in Getting Cardiac Arrest Patients to the Cath Lab

Brain injury is the bigger worry for most people, trial finds

European CVD Prevention Guide Leans on Age Stratification

Update has new risk assessment score but goes easy on blood pressure

Lower BP Targets Again Affirmed in Major Trial

STEP trial from China shows major benefits in older population

Nonsteroidal MRA Drug Cuts Risks in Earlier Diabetic Kidney Disease

Urine screening urged after trial shows benefit of treating cases with preserved kidney function

Mineral Oil Likely Accounts for Some -- But Not All -- of Vascepa's ASCVD Benefit

Danish study fans the flames of REDUCE-IT controversy

Add FFR to Diagnostic Angiography? Don't Bother

RIPCORD2 gives resounding "no" on all counts

Polypills Ready for Prime Time in Large Swaths of People, Researchers Say

Question now is how to implement fixed-dose combo therapy in clinical practice

His Bundle Pacing Stars in European Guidelines

Revised edition could signal coming U.S. recommendations too

Ablation, CRT Boost Survival in Permanent Afib With Narrow QRS

APAF-CRT trial reinforces the case for expanded CRT indication

One Month of DAPT Reasonable in Patients at High Bleeding Risk

MASTER DAPT trial included "all-comer HBR population," but results were with one specific stent

Edoxaban: A Mixed Bag for TAVR Patients Needing Anticoagulation

Weighing positive efficacy data against excess GI bleeds

Revamped Valve Disease Guideline: Europe Sees Nearly Eye to Eye With U.S.

There is a different approach to deciding the suitability of TAVR, however

A Familiar Drug Can Keep Early-Stage HCM at Bay

Treatment with valsartan most beneficial when started early?

Empagliflozin Improves Outcomes in HFpEF Patients

"A major win" for heart failure with preserved ejection fraction, says editorialist

New Heart Failure Guidelines Released, but Are They Already Out of Date?

Results of EMPEROR-Preserved contradict guidance

Milder Heart Failure Might Benefit From Implantable Monitors

Randomized trial signals benefit, albeit hampered by the pandemic

Loop Recorder Often Finds Major Arrhythmias in Risky Group Post MI

Serious events common in group with an LVEF of 36% to 50% and autonomic dysfunction

Deadly Arrhythmias Less of a Risk for HF Patients on Dapagliflozin

DAPA-HF analysis further explores mechanism of SGLT2 inhibitor's heart benefits

Heart Failure Again Takes Center Stage at ESC

EMPEROR-Preserved, new guidelines, and more to come

Kidney Disease No Barrier to Effient Benefit in ACS

Trial analysis supports superiority over ticagrelor regardless of eGFR

Does Ejection Fraction Matter Anymore?

Experts debate whether familiar metric still has a place in heart failure management

ESC Offers Sports, Exercise Guide for Heart Disease Patients

Addresses broad spectrum and specific conditions

'Definitive Data': Continuing ACE/ARB Tx Safe in COVID-19

Randomized trial affirms no harm in mild to moderate coronavirus cases

REALITY Check: Stricter RBC Transfusion Safe for Anemic MI Patients

Restrictive strategy makes sense for clinical outcomes, costs

Vascepa Mechanism Becomes Clearer... As Do Vessels

Treatment tied to regression of atherosclerosis in imaging-based EVAPORATE

Colchicine Scores for CV Secondary Prevention

LoDoCo2 trial finds substantial benefit, but questions linger

SGLT2 Inhibitor Wows in Chronic Kidney Disease

DAPA-CKD shows fewer renal events, prolonged overall survival

PARALLAX Trial: Mixed Results With Entresto in HFpEF

No boost in 6-minute walk test, but some heart failure biomarkers did improve

Antianginal Tx Fails to Make a Difference After Coronary Stenting

Prophylactic trimetazidine doesn't enhance optimal medical therapy

Aspirin Alone Best Bet for Majority of Post-TAVR Patients

Lessons from DAPT in PCI do not translate to TAVR, researchers find

2